ALVO Alvotech

Nasdaq alvotech.com


$ 5.18 $ -0.21 (-3.9 %)    

Thursday, 20-Nov-2025 14:13:33 EST
QQQ $ 589.02 $ -22.62 (-3.7 %)
DIA $ 459.11 $ -7.57 (-1.62 %)
SPY $ 655.38 $ -17.52 (-2.6 %)
TLT $ 89.26 $ 0.27 (0.3 %)
GLD $ 374.10 $ -1.08 (-0.29 %)
$ 5.23
$ 5.39
$ 5.15 x 67
$ 5.18 x 100
$ 5.16 - $ 5.40
$ 4.70 - $ 13.70
277,942
na
1.58B
$ 0.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ubs-maintains-buy-on-alvotech-lowers-price-target-to-10

UBS analyst Ashwani Verma maintains Alvotech (NASDAQ:ALVO) with a Buy and lowers the price target from $13 to $10.

 alvotech-lowers-fy2025-sales-guidance-from-600000m-700000m-to-570000m-600000m-vs-592949m-est

Alvotech (NASDAQ:ALVO) lowers FY2025 sales outlook from $600.000 million-$700.000 million to $570.000 million-$600.000 million ...

 alvotech-q3-eps-002-inline-sales-113744m-miss-117203m-estimate

Alvotech (NASDAQ:ALVO) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is unchang...

 alvotech-and-advanz-pharma-receive-uk-mhra-approval-for-gobivaz-biosimilar-across-multiple-indications

Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for pa...

 deutsche-bank-downgrades-alvotech-to-hold-lowers-price-target-to-8

Deutsche Bank analyst Niall Alexander downgrades Alvotech (NASDAQ:ALVO) from Buy to Hold and lowers the price target from $1...

 alvotech-shares-plunge-33-after-fda-flags-issues

Alvotech shares decline after the FDA issues a complete response letter for its Simponi biosimilar, leading to a lower 2025 rev...

 morgan-stanley-upgrades-alvotech-to-overweight-announces-14-price-target

Morgan Stanley analyst Thibault Boutherin upgrades Alvotech (NASDAQ:ALVO) from Equal-Weight to Overweight and announces $14 ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION